Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypertension

Free Subscription Articles published in Kidney Int Retrieve available abstracts of 38 articles: HTML format

Single Articles

April 2024
1. HORN KW, Shah SS, Skoll D, Carter D, et al
   The Case | Proximal muscle weakness, hypertension, and electrolyte abnormalities.
   Kidney Int. 2024;105:895-896.
   PubMed    
   
   
   
2. MOK Y, Matsushita K
   Integrating essence of "time" for blood pressure control in nephrology care.
   Kidney Int. 2024;105:673-674.
   PubMed     Abstract available
   
   
   
3. ALCALDE-ORTIZ ML, Jaramillo-Arriaga F, Ibarra-Orenday D, Gonzalez-Dominguez SI, et al
   Pediatric kidney dimensions and risk of persistent albuminuria in Mexican adolescents.
   Kidney Int. 2024;105:824-834.
   PubMed     Abstract available
   
   
   March 2024
4. LUYCKX VA, Tuttle KR, Abdellatif D, Correa-Rotter R, et al
   Mind the gap in kidney care: translating what we know into what we do.
   Kidney Int. 2024;105:406-417.
   PubMed     Abstract available
   
   
   December 2023
5. PARK CH, Kim HW, Joo YS, Park JT, et al
   Findings from the KNOW-CKD Study indicates that higher systolic blood pressure time in target range is associated with a lower risk of chronic kidney disease progression.
   Kidney Int. 2023 Dec 28:S0085-2538(23)00918-3. doi: 10.1016/j.kint.2023.
   PubMed     Abstract available
   
   
   
6. D'IZARNY-GARGAS T, Isnard P, Boudhabhay I, Buob D, et al
   The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms.
   Kidney Int. 2023;104:1206-1218.
   PubMed     Abstract available
   
   
   November 2023
7. WEI S, Su L, Gao Q
   Initiation of diuretics or calcium channel blockers on the top of renin-angiotensin system inhibitors on kidney outcome: which is better?
   Kidney Int. 2023;104:1036-1037.
   PubMed    
   
   
   August 2023
8. FINE LG
   The power of "negative" experiments: Harry Goldblatt's pathway to discovering how renal ischemia causes hypertension.
   Kidney Int. 2023;104:218-220.
   PubMed    
   
   
   
9. EMMONS BR, Batal I, Radhakrishnan J, Husain SA, et al
   Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort.
   Kidney Int. 2023;104:394-397.
   PubMed    
   
   
   July 2023
10. HONG S, Kim KS, Han K, Park CY, et al
    A cohort study found a high risk of end-stage kidney disease associated with acromegaly.
    Kidney Int. 2023 Jul 23:S0085-2538(23)00501-X. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    
11. VOGT L, Marques FZ, Fujita T, Hoorn EJ, et al
    Novel mechanisms of salt-sensitive hypertension.
    Kidney Int. 2023 Jul 14:S0085-2538(23)00493-3. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    
12. FENG W, Guan Z, Ying WZ, Xing D, et al
    Matrix metalloproteinase-9 regulates afferent arteriolar remodeling and function in hypertension-induced kidney disease.
    Kidney Int. 2023 Jul 7:S0085-2538(23)00489-1. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    June 2023
13. FAUCON AL, Fu EL, Stengel B, Mazhar F, et al
    A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality.
    Kidney Int. 2023 Jun 15:S0085-2538(23)00418-0. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available
    
    
    May 2023
14. SHOLOKH A, Walter S, Marko L, McMurray BJ, et al
    Mutant phosphodiesterase 3A protects the kidney from hypertension-induced damage.
    Kidney Int. 2023 May 25:S0085-2538(23)00389-7. doi: 10.1016/j.kint.2023.
    PubMed    
    
    
    
15. SMITH JP, Sequeira-Lopez MLS, Gomez RA
    A novel role for the histone modifier PRDM6 and an opportunity to understand hypertension.
    Kidney Int. 2023 May 24:S0085-2538(23)00385-X. doi: 10.1016/j.kint.2023.
    PubMed    
    
    
    January 2023
16. FERNANDES-ROSA FL, Boulkroun S, Fedlaoui B, Hureaux M, et al
    New advances in endocrine hypertension: from genes to biomarkers.
    Kidney Int. 2023 Jan 13:S0085-2538(23)00009-1. doi: 10.1016/j.kint.2022.
    PubMed     Abstract available
    
    
    
17. VAN DER GIET M
    How should blood pressure be measured? Con: the peripheral blood pressure is sufficient.
    Kidney Int. 2023;103:38-40.
    PubMed    
    
    
    
18. SHARMAN JE
    Value of measuring central blood pressure in clinical practice.
    Kidney Int. 2023;103:34-38.
    PubMed    
    
    
    December 2022
19. CASTANEDA-BUENO M, Ellison DH
    Blood pressure effects of sodium transport along the distal nephron.
    Kidney Int. 2022;102:1247-1258.
    PubMed     Abstract available
    
    
    November 2022
20. SHANKLAND SJ, Wessely O
    Zoning in on podocytes.
    Kidney Int. 2022;102:966-968.
    PubMed     Abstract available
    
    
    
21. HARUHARA K, Kanzaki G, Sasaki T, Hatanaka S, et al
    Associations between nephron number and podometrics in human kidneys.
    Kidney Int. 2022;102:1127-1135.
    PubMed     Abstract available
    
    
    October 2022
22. GARIMELLA PS, du Toit C, Le NN, Padmanabhan S, et al
    A genomic deep field view of hypertension.
    Kidney Int. 2022 Oct 29. pii: S0085-2538(22)00911.
    PubMed     Abstract available
    
    
    July 2022
23. SURAPANENI A, Schlosser P, Zhou L, Liu C, et al
    Identification of 969 protein quantitative trait loci in an African American population with kidney disease attributed to hypertension.
    Kidney Int. 2022 Jul 20. pii: S0085-2538(22)00547.
    PubMed     Abstract available
    
    
    June 2022
24. TOMASZEWSKI M, Morris AP, Howson JM, Franceschini N, et al
    Kidney omics in hypertension - from statistical associations to biological mechanisms and clinical applications.
    Kidney Int. 2022 Jun 8. pii: S0085-2538(22)00442.
    PubMed     Abstract available
    
    
    
25. NODA R, Han W, Shibagaki Y, Yazawa M, et al
    Renovascular hypertension secondary to massive iliopsoas hematoma.
    Kidney Int. 2022;101:1304.
    PubMed    
    
    
    
26. SUBBIAH A, Bhowmik D
    KDIGO recommendations on blood pressure management in chronic kidney disease.
    Kidney Int. 2022;101:1299.
    PubMed    
    
    
    February 2022
27. IX JH, Thomson CRV, Cheung AK, Mann JFE, et al
    Response to "Diagnosis and Treatment of Arterial Hypertension 2021".
    Kidney Int. 2022 Feb 12. pii: S0085-2538(22)00108.
    PubMed    
    
    
    
28. OTT C, Schmieder RE
    Response to: "Response to "Diagnosis and Treatment of Arterial Hypertension 2021".
    Kidney Int. 2022 Feb 12. pii: S0085-2538(22)00109.
    PubMed    
    
    
    December 2021
29. TURNER M, Staplin N
    UMOD-ulating CKD risk: untangling the relationship between urinary uromodulin, blood pressure, and kidney disease.
    Kidney Int. 2021;100:1168-1170.
    PubMed     Abstract available
    
    
    October 2021
30. OTT C, Schmieder RE
    Diagnosis and Treatment of Arterial Hypertension 2021.
    Kidney Int. 2021 Oct 29. pii: S0085-2538(21)01023.
    PubMed     Abstract available
    
    
    
31. ELIJOVICH F
    Ultrasound renal denervation for hypertension: impact of the RADIANCE-HTN-TRIO trial on future management of resistant hypertension.
    Kidney Int. 2021 Oct 4. pii: S0085-2538(21)00927.
    PubMed    
    
    
    August 2021
32. BAILEY MA
    Salbutamol and salt-sensitive hypertension.
    Kidney Int. 2021;100:272-275.
    PubMed     Abstract available
    
    
    
33. LEBLANC N
    Targeting TMEM16A-encoded Ca(2+)-activated Cl(-) channels: a new paradigm for antihypertensive therapy?
    Kidney Int. 2021;100:269-272.
    PubMed     Abstract available
    
    
    April 2021
34. SANTORIELLO D, Bomback AS, Kudose S, Batal I, et al
    Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.
    Kidney Int. 2021 Apr 12. pii: S0085-2538(21)00379.
    PubMed     Abstract available
    
    
    
35. LUO S, Feofanova EV, Tin A, Tung S, et al
    Genome-wide association study of serum metabolites in the African American Study of Kidney Disease and Hypertension.
    Kidney Int. 2021 Apr 7. pii: S0085-2538(21)00361.
    PubMed     Abstract available
    
    
    
36. CIL O, Chen X, Askew Page HR, Baldwin SN, et al
    A small molecule inhibitor of the chloride channel TMEM16A blocks vascular smooth muscle contraction and lowers blood pressure in spontaneously hypertensive rats.
    Kidney Int. 2021 Apr 6. pii: S0085-2538(21)00360.
    PubMed     Abstract available
    
    
    March 2021
37. FOTI KE, Wang D, Chang AR, Selvin E, et al
    Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States.
    Kidney Int. 2021;99:686-695.
    PubMed     Abstract available
    
    
    November 2019
38. CHIANG HP, Chiu YW, Lee JJ, Hung CC, et al
    Blood pressure modifies outcomes in patients with stage 3 to 5 chronic kidney disease.
    Kidney Int. 2019 Nov 7. pii: S0085-2538(19)31114.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.